Cost Effectiveness of Patient Self-Managed Warfarin Compared with Direct Oral Anticoagulants in Atrial Fibrillation: An Economic Evaluation in a Danish Healthcare Sector Setting.
Sabine Michelsen RaunbakAnne Sig SørensenLouise HansenFlemming SkjøthTorben Bjerregaard LarsenLars Holger EhlersPublished in: PharmacoEconomics - open (2022)
The present study found that PSM is dominant (i.e., both more effective and cost saving) compared with DOACs, adding to the scarce evidence of the comparative cost effectiveness of PSM and DOACs in NVAF.